Memory T cells and their exhaustive differentiation in allograft tolerance and rejection

Current Opinion in Organ Transplantation

Volumn 17, Issue 1, 2012, Pages 15-19

  Valujskikh, Anna ^a   Li, Xian C ^b,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

antigen persistence; exhaustion; T cells; tolerance

Indexed keywords

GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; LYMPHOCYTE DIFFERENTIATION; MEMORY T LYMPHOCYTE; NONHUMAN; PHENOTYPE; REVIEW; TRANSPLANTATION TOLERANCE;

ANIMALS; CELL DIFFERENTIATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOLOGIC MEMORY; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84856080980     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32834ee443     Document Type: Review

References (34)

1. Wherry EJ. T cell exhaustion. Nat Rev Immunol 2011; 12:492-499.
2. Shin H, Wherry EJ. CD8 T cell dysfunction during chronic viral infection. Curr Opin Immunol 2007; 19:408-415. (Pubitemid 47284857)
3. Crawford A, Wherry EJ. The diversity of costimulatory and inhibitory receptor pathways and the regulation of antiviral T cell responses. Curr Opin Immunol 2009; 21:179-186.
4. Freeman GJ, Wherry EJ, Ahmed R, Sharpe AH. Reinvigorating exhausted HIVspecific T cells via PD-1-PD-1 ligand blockade. J Exp Med 2006; 203:2223-2227. (Pubitemid 44498355)
5. 8+ T cell survival in HIV infection. J Exp Med 2006; 203:2281-2292. (Pubitemid 44498363)
6. Barber DL, Wherry EJ, Masopust D, et al. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 2006; 439:682-687. (Pubitemid 43237609)
7. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990; 248:1349-1356.
8. 8+ T cell exhaustion during chronic viral infection. Immunity 2009; 31:309-320.
9. Chan Y-H, Chiang M-F, Tsai Y-C, et al. Absence of the transcriptional repressor Blimp-1 in hematopoietic lineages reveals its role in dendritic cell homeostatic development and function. J Immunol 2009; 183:7039-7046.
10. 8+ T cells shows that PD-1 inhibits T cell function by upregulating BATF. Nat Med 2010; 16:1147-1151.
11. Betz BC, Jordan-Williams KL, Wang C, et al. Batf coordinates multiple aspects of B and T cell function required for normal antibody responses. J Exp Med 2010; 207:933-942.
12. Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev 2009; 229:271-293.
13. 8+ T cells and prolonged graft survival in a CTLA4-dependent manner. J Immunol 2000; 164:512-521. (Pubitemid 30013028)
14. Hernandez-Fuentes MP, Lechler RI. A 'biomarker signature' for tolerance in transplantation. Nat Rev Nephrol 2010; 6:606-613.
15. Li XC, Turka LA. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol 2010; 6:577-583.
16. He C, Schenk S, Zhang Q, et al. Effects of T cell frequency and graft size on transplant outcome in mice. J Immunol 2004; 172:240-247. (Pubitemid 38020477)
17. 25+ T cells. J Immunol 2005; 174:3741-3748. (Pubitemid 40354086)
18. Qian S, L.U. L, Fu F, et al. Apoptosis within spontaneously accepted mouse liver allografts: evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 1997; 158:4654-4661. (Pubitemid 127483783)
19. Singh NJ, Chen C, Schwartz RH. The impact of T cell intrinsic antigen adaptation on peripheral immune tolerance. PloS Biol 2006; 4:e340.
20. 4+ T cells adapted to persistent systemic antigen. J Immunol 2009; 183:4284-4291.
21. Swanson SJ, Hale DA, Mannon RB, et al. Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy. Lancet 2002; 360:1662-1664. (Pubitemid 35379741)
22. 8+ T cells and drives their eventual exhaustion in mouse models of bone marrow transplantation. J Clin Investig 2010; 120:3855-3868.
23. 8+ T cells from asymptomatic pediatric thoracic transplant patients carrying chronic high EBV loads display contrasting features: Activated phenotype and exhausted function. J Immunol 2011; 186:5854-5862.
24. Ito T, Ueno T, Clarkson MR, et al. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol 2005; 174:6648-6656. (Pubitemid 40705625)
25. Wang L, Han R, Hancock WW. Programmed cell death 1 (PD-1) and its ligand PD-L1 are required for allograft tolerance. Eur J Immunol 2007; 37:2983-2990. (Pubitemid 47578316)
26. Yang J, Popoola J, Khandwala S, et al. Critical role of donor tissue expression of programmed death ligand-1 in regulating cardiac allograft rejection and vasculopathy. Circulation 2008; 117:660-669.
27. Kuchroo VK, Dardalhon V, Xiao S, Anderson AC. New roles for TIM family members in immune regulation. Nat Rev Immunol 2008; 8:577-580.
28. Boenisch O, D'Addio F, Watanabe T, et al. TIM-3: A novel regulatory molecule of alloimmune activation. J Immunol 2010; 185:5806-5819.
29. Sánchez-Fueyo A, Tian J, Picarella D, et al. TIM-3 inhibits T helper type 1- mediated auto- and alloimmune responses and promotes immunological tolerance. Nat Immunol 2003; 4:1093-1101. (Pubitemid 37428037)
30. Sakai K, Kawata E, Ashihara E, et al. Galectin-9 ameliorates acuteGVHdisease through the induction of T-cell apoptosis. Eur J Immunol 2011; 41:67-75.
31. HeW,Fang Z,Wang F, et al. Galectin-9 significantly prolongs the survival of fully mismatched cardiac allografts in mice. Transplantation 2009; 88:782-790.
32. Triebel F. LAG-3: A regulator of T cell DC responses and its use in therapeutic vaccination. Trends Immunol 2003; 24:619-622. (Pubitemid 37485908)
33. Haudebourg T, Dugast AS, Coulon F, et al. Depletion of LAG-3 positive cells in cardiac allograft reveals their role in rejection and tolerance. Transplantation 2007; 84:1500-1506. (Pubitemid 350294726)
34. Lucas CL, Workman CJ, Beyaz S, et al. LAG-3, TGF-b, and cell-intrinsic PD-1 inhibitory pathways contribute to CD8 but not CD4 T-cell tolerance induced by allogeneic BMT with anti-CD40L. Blood 2011; 117:5532-5540.